NO981072L - Neural transplantasjon ved anvendelse av pluripotente neuroepitelceller - Google Patents
Neural transplantasjon ved anvendelse av pluripotente neuroepitelcellerInfo
- Publication number
- NO981072L NO981072L NO981072A NO981072A NO981072L NO 981072 L NO981072 L NO 981072L NO 981072 A NO981072 A NO 981072A NO 981072 A NO981072 A NO 981072A NO 981072 L NO981072 L NO 981072L
- Authority
- NO
- Norway
- Prior art keywords
- neuroepithelial cells
- pluripotent neuroepithelial
- neural transplantation
- cells
- pluripotent
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
- A61K35/30—Nerves; Brain; Eyes; Corneal cells; Cerebrospinal fluid; Neuronal stem cells; Neuronal precursor cells; Glial cells; Oligodendrocytes; Schwann cells; Astroglia; Astrocytes; Choroid plexus; Spinal cord tissue
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
- C12N5/10—Cells modified by introduction of foreign genetic material
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
- C12N5/06—Animal cells or tissues; Human cells or tissues
- C12N5/0602—Vertebrate cells
- C12N5/0618—Cells of the nervous system
- C12N5/0623—Stem cells
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2500/00—Specific components of cell culture medium
- C12N2500/05—Inorganic components
- C12N2500/10—Metals; Metal chelators
- C12N2500/20—Transition metals
- C12N2500/24—Iron; Fe chelators; Transferrin
- C12N2500/25—Insulin-transferrin; Insulin-transferrin-selenium
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2500/00—Specific components of cell culture medium
- C12N2500/90—Serum-free medium, which may still contain naturally-sourced components
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2501/00—Active agents used in cell culture processes, e.g. differentation
- C12N2501/10—Growth factors
- C12N2501/115—Basic fibroblast growth factor (bFGF, FGF-2)
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2501/00—Active agents used in cell culture processes, e.g. differentation
- C12N2501/20—Cytokines; Chemokines
- C12N2501/24—Interferons [IFN]
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2501/00—Active agents used in cell culture processes, e.g. differentation
- C12N2501/30—Hormones
- C12N2501/38—Hormones with nuclear receptors
- C12N2501/39—Steroid hormones
- C12N2501/392—Sexual steroids
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2501/00—Active agents used in cell culture processes, e.g. differentation
- C12N2501/30—Hormones
- C12N2501/38—Hormones with nuclear receptors
- C12N2501/395—Thyroid hormones
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2501/00—Active agents used in cell culture processes, e.g. differentation
- C12N2501/90—Polysaccharides
- C12N2501/91—Heparin
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Biomedical Technology (AREA)
- Chemical & Material Sciences (AREA)
- Cell Biology (AREA)
- Biotechnology (AREA)
- Zoology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Health & Medical Sciences (AREA)
- Neurosurgery (AREA)
- Organic Chemistry (AREA)
- Developmental Biology & Embryology (AREA)
- Neurology (AREA)
- Genetics & Genomics (AREA)
- Wood Science & Technology (AREA)
- Medicinal Chemistry (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Immunology (AREA)
- Biochemistry (AREA)
- Microbiology (AREA)
- Virology (AREA)
- Epidemiology (AREA)
- General Engineering & Computer Science (AREA)
- Ophthalmology & Optometry (AREA)
- Hematology (AREA)
- Molecular Biology (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Urology & Nephrology (AREA)
- Physics & Mathematics (AREA)
- Hospice & Palliative Care (AREA)
- Food Science & Technology (AREA)
- Psychiatry (AREA)
- Analytical Chemistry (AREA)
- General Physics & Mathematics (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GBGB9518606.0A GB9518606D0 (en) | 1995-09-12 | 1995-09-12 | Neural transplantation |
PCT/GB1996/002251 WO1997010329A1 (en) | 1995-09-12 | 1996-09-12 | Neural transplantation using pluripotent neuroepithelial cells |
Publications (2)
Publication Number | Publication Date |
---|---|
NO981072D0 NO981072D0 (no) | 1998-03-11 |
NO981072L true NO981072L (no) | 1998-05-12 |
Family
ID=10780583
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
NO981072A NO981072L (no) | 1995-09-12 | 1998-03-11 | Neural transplantasjon ved anvendelse av pluripotente neuroepitelceller |
Country Status (21)
Country | Link |
---|---|
US (3) | US7048921B2 (hu) |
EP (1) | EP0850298B1 (hu) |
JP (1) | JP4280872B2 (hu) |
KR (1) | KR19990044606A (hu) |
CN (1) | CN1193345A (hu) |
AT (1) | ATE242316T1 (hu) |
AU (1) | AU711563B2 (hu) |
CA (1) | CA2231436C (hu) |
CZ (1) | CZ296669B6 (hu) |
DE (1) | DE69628566T2 (hu) |
DK (1) | DK0850298T3 (hu) |
ES (1) | ES2196172T3 (hu) |
GB (1) | GB9518606D0 (hu) |
HK (1) | HK1009154A1 (hu) |
HU (1) | HUP9802091A3 (hu) |
NO (1) | NO981072L (hu) |
PL (1) | PL186777B1 (hu) |
PT (1) | PT850298E (hu) |
RU (1) | RU2185833C2 (hu) |
SK (1) | SK285816B6 (hu) |
WO (1) | WO1997010329A1 (hu) |
Families Citing this family (17)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CZ138397A3 (en) | 1994-11-08 | 1997-10-15 | Bradley Michael John Stringer | Human cellular lines |
GB9518606D0 (en) | 1995-09-12 | 1995-11-15 | Inst Of Psychiatry | Neural transplantation |
GB9904281D0 (en) * | 1999-02-24 | 1999-04-21 | Reneuron Ltd | Transplantation |
GB9907243D0 (en) | 1999-03-29 | 1999-05-26 | Reneuron Ltd | Therapy |
KR100801764B1 (ko) * | 1999-09-17 | 2008-02-05 | 레뉴런 리미티드 | 세포의 조건부 불멸화 |
US6399384B1 (en) * | 1999-09-17 | 2002-06-04 | Reneuron Limited | Conditional immortalization of cells |
US6465215B1 (en) | 1999-12-14 | 2002-10-15 | Reneuron Limited | Identification of cells for transplantation |
GB0005856D0 (en) * | 2000-03-10 | 2000-05-03 | Reneuron Ltd | Genetic constructs |
GB0125773D0 (en) * | 2001-10-26 | 2001-12-19 | Reneuron Ltd | Constructs |
DE602005002430T2 (de) | 2004-09-30 | 2008-06-19 | Reneuron Ltd., Guildford | Zelllinie |
CA2725953A1 (en) * | 2007-05-29 | 2008-12-11 | Christopher B. Reid | Methods for production and uses of multipotent cell populations, pluripotent cell populations, neuronal cell populations, and muscle cell populations |
GB0822246D0 (en) | 2008-12-05 | 2009-01-14 | Reneuron Ltd | Composition |
GB0902034D0 (en) | 2009-02-06 | 2009-03-11 | Reneuron Ltd | Method |
GB201011589D0 (en) * | 2010-07-09 | 2010-08-25 | Reneuron Ltd | Therapeutic cells |
US20150232662A1 (en) * | 2014-02-20 | 2015-08-20 | Sabic Innovative Plastics Ip B.V. | Thermoplastic composition and article |
US20170173114A1 (en) * | 2014-05-07 | 2017-06-22 | Joslin Diabetes Center, Inc. | Methods and compositions for induction of ucp1 expression |
CN116590345B (zh) * | 2023-05-06 | 2024-01-30 | 北京中医药大学 | 永生化小鼠足细胞系及其制备方法、分化方法和应用 |
Family Cites Families (41)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US1662A (en) * | 1840-06-27 | ariel nobris | ||
US146821A (en) * | 1874-01-27 | Improvement in nose-pieces of nail-plate feeders | ||
US28510A (en) * | 1860-05-29 | John e | ||
US147873A (en) * | 1874-02-24 | Improvement in nasal yokes for animals | ||
US203483A (en) * | 1878-05-07 | Improvement in honey-boxes | ||
US913443A (en) * | 1908-08-13 | 1909-02-23 | Webster Full Expansion Rotary Engine Company | Rotary engine. |
NZ226750A (en) * | 1987-10-29 | 1990-09-26 | Amrad Corp Ltd | Immortalisation of neural precursor cells by introducing a retrovirus vector containing a myc-oncogene |
EP0428519B1 (en) | 1988-04-12 | 1993-06-16 | Massachusetts Institute Of Technology | Method for manipulation of the cell types of eukaryotes |
US5270191A (en) | 1988-04-12 | 1993-12-14 | Massachusetts Institute Of Technology | Method for manipulation of the cell types of eukaryotes |
EP0395106B1 (en) * | 1989-04-27 | 1994-07-06 | Ajinomoto Co., Inc. | Demethylallosamidin and a process for production thereof |
US5399493A (en) | 1989-06-15 | 1995-03-21 | The Regents Of The University Of Michigan | Methods and compositions for the optimization of human hematopoietic progenitor cell cultures |
WO1991009936A1 (en) * | 1989-12-26 | 1991-07-11 | Hana Biologics, Inc. | Proliferated neuron progenitor cell product and process |
US5612211A (en) | 1990-06-08 | 1997-03-18 | New York University | Stimulation, production and culturing of hematopoietic progenitor cells by fibroblast growth factors |
RU2028089C1 (ru) * | 1990-10-16 | 1995-02-09 | Украинский научно-исследовательский институт нейрохирургии | Способ лечения апаллического синдрома |
US5851832A (en) | 1991-07-08 | 1998-12-22 | Neurospheres, Ltd. | In vitro growth and proliferation of multipotent neural stem cells and their progeny |
ATE240389T1 (de) * | 1991-07-08 | 2003-05-15 | Neurospheres Holdings Ltd | Auf wachstumsfaktoren reagierende neurale vorläuferzellen, die in vitro vermehrt werden können. |
KR950700403A (ko) | 1992-03-04 | 1995-01-16 | 죤 제이. 쉬바르츠 | 조혈 간세포의 배양 및 그것의 유전공학(culturing of hematopoietic stem cells and their genetic engineering) |
US5753491A (en) | 1993-04-13 | 1998-05-19 | Us Health | Use of neuro-derived fetal cell lines for transplantation therapy |
DK0696205T3 (da) | 1993-04-13 | 2002-05-13 | Us Gov Health & Human Serv | Anvendelse af neuro-afledte fetale cellelinier til transplantationsterapi |
CZ138397A3 (en) | 1994-11-08 | 1997-10-15 | Bradley Michael John Stringer | Human cellular lines |
CN1170435A (zh) * | 1994-11-14 | 1998-01-14 | 纽罗斯菲里斯控股有限公司 | 神经干细胞增殖的调节 |
US5843780A (en) | 1995-01-20 | 1998-12-01 | Wisconsin Alumni Research Foundation | Primate embryonic stem cells |
GB9517263D0 (en) * | 1995-08-23 | 1995-10-25 | Cancer Res Campaign Tech | Expression systems |
GB9518606D0 (en) * | 1995-09-12 | 1995-11-15 | Inst Of Psychiatry | Neural transplantation |
US5588692A (en) * | 1995-10-11 | 1996-12-31 | General Motors Corporation | Push-out vehicle side door |
NZ334016A (en) | 1996-08-19 | 2000-08-25 | Univ Massachusetts | Embryonic stem cell lines produced by cross species nuclear transplantation |
SE9604322D0 (sv) * | 1996-11-25 | 1996-11-25 | Astra Ab | Bacterial antigens and vaccine compositions II |
US20020123143A1 (en) | 1997-08-22 | 2002-09-05 | Jean Toma | Multipotent stem cells from peripheral tissues and uses thereof |
WO1999056759A1 (en) * | 1998-05-07 | 1999-11-11 | University Of South Florida | Bone marrow cells as a source of neurons for brain and spinal cord repair |
US5958767A (en) | 1998-08-14 | 1999-09-28 | The Children's Medical Center Corp. | Engraftable human neural stem cells |
GB9904281D0 (en) | 1999-02-24 | 1999-04-21 | Reneuron Ltd | Transplantation |
GB9907243D0 (en) * | 1999-03-29 | 1999-05-26 | Reneuron Ltd | Therapy |
US6399384B1 (en) | 1999-09-17 | 2002-06-04 | Reneuron Limited | Conditional immortalization of cells |
US6465215B1 (en) * | 1999-12-14 | 2002-10-15 | Reneuron Limited | Identification of cells for transplantation |
JP2004500824A (ja) * | 2000-03-09 | 2004-01-15 | クリオ−セル インターナショナル インコーポレーティッド | 脳および脊髄の修復のための神経組織源としてのヒト臍帯血 |
US7250294B2 (en) | 2000-05-17 | 2007-07-31 | Geron Corporation | Screening small molecule drugs using neural cells differentiated from human embryonic stem cells |
AU2001264763A1 (en) | 2000-06-05 | 2001-12-17 | University Of South Florida | Human mesenchymal progenitor cell |
US7049072B2 (en) * | 2000-06-05 | 2006-05-23 | University Of South Florida | Gene expression analysis of pluri-differentiated mesenchymal progenitor cells and methods for diagnosing a leukemic disease state |
WO2003029432A2 (en) | 2001-10-03 | 2003-04-10 | University Of South Florida | Human mesenchymal progenitor cell |
GB0125773D0 (en) * | 2001-10-26 | 2001-12-19 | Reneuron Ltd | Constructs |
DE602005002430T2 (de) * | 2004-09-30 | 2008-06-19 | Reneuron Ltd., Guildford | Zelllinie |
-
1995
- 1995-09-12 GB GBGB9518606.0A patent/GB9518606D0/en active Pending
-
1996
- 1996-09-12 JP JP51175697A patent/JP4280872B2/ja not_active Expired - Lifetime
- 1996-09-12 SK SK306-98A patent/SK285816B6/sk unknown
- 1996-09-12 CN CN96196376A patent/CN1193345A/zh active Pending
- 1996-09-12 RU RU98107327/14A patent/RU2185833C2/ru not_active IP Right Cessation
- 1996-09-12 CZ CZ0055898A patent/CZ296669B6/cs not_active IP Right Cessation
- 1996-09-12 PT PT96930260T patent/PT850298E/pt unknown
- 1996-09-12 KR KR1019980701856A patent/KR19990044606A/ko not_active Application Discontinuation
- 1996-09-12 WO PCT/GB1996/002251 patent/WO1997010329A1/en active IP Right Grant
- 1996-09-12 DK DK96930260T patent/DK0850298T3/da active
- 1996-09-12 PL PL96325646A patent/PL186777B1/pl unknown
- 1996-09-12 HU HU9802091A patent/HUP9802091A3/hu unknown
- 1996-09-12 ES ES96930260T patent/ES2196172T3/es not_active Expired - Lifetime
- 1996-09-12 AT AT96930260T patent/ATE242316T1/de not_active IP Right Cessation
- 1996-09-12 DE DE69628566T patent/DE69628566T2/de not_active Expired - Lifetime
- 1996-09-12 AU AU69375/96A patent/AU711563B2/en not_active Expired
- 1996-09-12 EP EP96930260A patent/EP0850298B1/en not_active Expired - Lifetime
- 1996-09-12 CA CA002231436A patent/CA2231436C/en not_active Expired - Lifetime
-
1998
- 1998-03-11 NO NO981072A patent/NO981072L/no not_active Application Discontinuation
- 1998-08-19 HK HK98110007A patent/HK1009154A1/xx not_active IP Right Cessation
-
2001
- 2001-01-12 US US09/760,274 patent/US7048921B2/en not_active Expired - Fee Related
-
2003
- 2003-02-28 US US10/376,119 patent/US20030147873A1/en not_active Abandoned
-
2005
- 2005-07-08 US US11/178,216 patent/US7371374B2/en not_active Expired - Fee Related
Also Published As
Publication number | Publication date |
---|---|
US7048921B2 (en) | 2006-05-23 |
RU2185833C2 (ru) | 2002-07-27 |
PL186777B1 (pl) | 2004-02-27 |
HUP9802091A3 (en) | 2001-01-29 |
DE69628566D1 (de) | 2003-07-10 |
JP4280872B2 (ja) | 2009-06-17 |
CA2231436A1 (en) | 1997-03-20 |
EP0850298A1 (en) | 1998-07-01 |
US20030147873A1 (en) | 2003-08-07 |
CZ296669B6 (cs) | 2006-05-17 |
EP0850298B1 (en) | 2003-06-04 |
SK285816B6 (sk) | 2007-09-06 |
PL325646A1 (en) | 1998-08-03 |
NO981072D0 (no) | 1998-03-11 |
KR19990044606A (ko) | 1999-06-25 |
JPH11513242A (ja) | 1999-11-16 |
ATE242316T1 (de) | 2003-06-15 |
US20010001662A1 (en) | 2001-05-24 |
PT850298E (pt) | 2003-09-30 |
AU6937596A (en) | 1997-04-01 |
HUP9802091A2 (hu) | 1998-12-28 |
DE69628566T2 (de) | 2004-05-06 |
ES2196172T3 (es) | 2003-12-16 |
CA2231436C (en) | 2007-07-17 |
WO1997010329A1 (en) | 1997-03-20 |
CZ55898A3 (cs) | 1998-06-17 |
SK30698A3 (en) | 1999-01-11 |
CN1193345A (zh) | 1998-09-16 |
DK0850298T3 (da) | 2003-09-15 |
US20060051326A1 (en) | 2006-03-09 |
US7371374B2 (en) | 2008-05-13 |
AU711563B2 (en) | 1999-10-14 |
GB9518606D0 (en) | 1995-11-15 |
HK1009154A1 (en) | 1999-05-28 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
NO981072L (no) | Neural transplantasjon ved anvendelse av pluripotente neuroepitelceller | |
WO2001036589A3 (en) | Human ex vivo immune system | |
DE69609222T2 (de) | Partikel auf Polyaminosäure(n)basis zur Verwendung als Wirkstoffträger sowie deren Herstellungsverfahren | |
WO1997012960A3 (en) | Solid support for use in cell cultivation, especially for the cultivation of liver cells, biological reactor containing said solid support and the use thereof in a bio-artificial liver system | |
ATE514772T1 (de) | Multipotente erwachsene stammzellen und verfahren zu deren isolierung | |
IL121790A0 (en) | Method for preventing and treating sensorineural hearing loss and vestibular disorders using glial cell line-derived neurotrophic factor (GDNF) protein product | |
IL143283A0 (en) | Medicinal product and method for treatment of conditions affecting neural stem cells or progenitor cells | |
MY113045A (en) | Waste treatment plant and process | |
GR3005297T3 (hu) | ||
DE69637709D1 (de) | Durch elektroporation vermittelter molekulartransfer in intakten pflanzen | |
ATE290385T1 (de) | Arzneimittel zur förderung der neuronalen zelldifferenzierung, die cyclische glycerophosphate und deren analoga enthalten | |
HUP9802531A2 (hu) | Eljárás haematopoeticus stem sejtek mobilizálására | |
ATE94764T1 (de) | Nasal applizierbares arzneimittel, verfahren zu seiner herstellung und seine verwendung. | |
DE58906338D1 (de) | Kombination von Angiotensin-Converting-Enzyme-Hemmern mit Kaliumkanal-Modulatoren sowie deren Verwendung in Arzneimitteln. | |
ATE103989T1 (de) | Monoklonale antikoerper gegen e7-protein des humanen papillomvirus typ 16, verfahren zu ihrer herstellung sowie ihre verwendung. | |
NO983917L (no) | Anvendelse av IL-7 for behandling av autoimmune sykdommer og sµrlig insulinavhengig diabetes mellitus | |
FR2740991B1 (fr) | Nouveaux extraits de plantes, leur procede de fabrication et leur utilisation dans les produits cosmetiques | |
AU7577091A (en) | Process for the artificial stimulation of cells and cyte culture device | |
WO2003040304A3 (en) | Method of proliferation in neurogenic regions | |
ATA15189A (de) | Humaner monoklonaler antikoerper, verfahren zu dessen herstellung, arzneimittel und hybridzelle | |
EP0142109A3 (en) | Macromolecules extracted from cultured mesenchymal cells for the treatment of degenerative diseases | |
NZ335534A (en) | Method of identifying potential pharmaceuticals from plant extracts | |
ATE334672T1 (de) | Ginkolide zur hemmung der membranexpression | |
DE69522706T2 (de) | Heterocyclische verbindungen, deren herstellung und verwendung | |
DE58902689D1 (de) | Disubstituierte naphthaline, verfahren zur herstellung sowie deren herbizide verwendung. |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FC2A | Withdrawal, rejection or dismissal of laid open patent application |